Discover Community Create You

Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Article

Treatment with Cannabinoids as a Promising Approach for Impairing Fibroblast Activation and Prostate Cancer Progression.

International journal of molecular sciences - 25 Jan 2020

Pietrovito Laura, Iozzo Marta, Bacci Marina, Giannoni Elisa, Chiarugi Paola

Abstract excerpt

Endo-, phyto- and synthetic cannabinoids have been proposed as promising anti-cancer agents able to impair cancer cells' behavior without affecting their non-transformed counterparts. However, cancer outcome depends not only on cancer cells' activity, but also on the stromal cells, which coevolve with cancer cells to sustain tumor progression. Here, we show for the first time that cannabinoid treatment impairs...

Read the complete abstract on PubMed

Topics

Share this publication in a Topic to start or enrich a Post.

Share to Androgens
Share to Benzoxazines

Methodology Data sources Editorial policy Privacy About Contact Helena Bioinformatics

Share to Cancer-Associated Fibroblasts

Share to Cannabinoids

Share to Morpholines

Share to Naphthalenes

Share to Receptor, Cannabinoid, CB2

Share to Tumor Microenvironment

Source

Open in PubMed Open full text

Identifiers

PMID: 31991773
DOI: 10.3390/ijms21030787
PMCID: PMC7037293

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 7 Sept 2026. Manifest publication-graph-cohort-2026-09-07.1.

Source receipt: pubmed, retrieved 7 Sept 2026.

Related research

Semantic proximity does not establish scientific evidence.

Research trail→

Click a neighbor to travelStep 1 · 12 closest

Treatment with Cannabinoids as a Promising Approach for Impairing Fibroblast Activation and Prostate Cancer Progression.PMID 31991773Read ↗

Zoledronic acid impairs stromal reactivity by inhibiting M2-macrophages polarization and prostate cancer-associated fibroblasts.Semantic proximity Read ↗

Silibinin prevents prostate cancer cell‐mediated differentiation of naïve fibroblasts into cancer‐associated fibroblast phenotype by targeting TGF β2Semantic proximity Read ↗

Tumor microenvironment and metabolism in prostate cancer.Semantic proximity Read ↗

Use of Cannabis and Cannabinoids for Treatment of CancerSemantic proximity Read ↗

Prostate Cancer Stem Cells: Viewing Signaling Cascades at a Finer Resolution.Semantic proximity Read ↗

Combination therapies with Wnt signaling inhibition: A better choice for prostate cancer treatmentSemantic proximity Read ↗

Gene expressional changes in prostate fibroblasts from cancerous tissueSemantic proximity Read ↗

Transient CB2 receptor activation triggers irreversible luminal differentiation via chromatin remodeling in breast cancerSemantic proximity Read ↗

Inhibition of glypican-1 expression induces an activated fibroblast phenotype in a human bone marrow-derived stromal cell-line.Semantic proximity Read ↗

Cancer-associated fibroblasts promote prostate tumor growth and progression through upregulation of cholesterol and steroid biosynthesis.Semantic proximity Read ↗

Persistent inflammation leads to proliferative neoplasia and loss of smooth muscle cells in a prostate tumor model.Semantic proximity Read ↗

SREBP-2 promotes stem cell-like properties and metastasis by transcriptional activation of c-Myc in prostate cancerSemantic proximity Read ↗

⌁Select a neighboring publication to make it the new centre.